Non-proprietary name Health Dictionary

The trade name of a drug registered by the pharmaceutical company which has developed and patented it. This protects the name, ingredients and manufacturing technique for a set period of time, and helps the company to recoup the often costly research and development needed to produce and test the drug. Doctors may prescribe a drug by its trade name or by its o?cial, approved name, although the NHS encourages the latter. (See GENERIC DRUG; PATENT.)... proprietary name

The term used for names devised or selected by the British Pharmacopoeia Commission for new drugs. European Union law (1992) requires the use of a Recommended International Non-proprietary Name (rINN) for medicinal substances. In most cases the British Approved Name (BAN) and rINN were the same when the legislation was introduced; where there were di?erences, the BAN was modi?ed to meet the new requirements.

Pharmaceutical manufacturers usually give proprietary (brand) names to the drugs they develop, though doctors in the NHS are expected to prescribe using approved – nonproprietary or generic – titles. Most nonproprietary titles are those in the European Pharmacopoeia, British Pharmacopoeia Commission or the British Pharmaceutical Codex. The USA has its own legislation and arrangements covering the naming and prescribing of medicines. (See PROPRIETARY NAME; GENERIC DRUG; PATENT.)... approved names for medicines

The o?cially approved name for a medicinal substance used in the UK. A 1992 European Union directive required the use of a Recommended International Non-proprietary Name (rINN) for these substances. Usually the BAN and rINN were identical; where there was a difference, the rINN nomenclature is now used. An exception is adrenaline, which remains the o?cial name in Europe with the rINN – epinephrine – being a synonym.... british approved names (ban)

A term for a drug patented for production by one company.... proprietary